The global research antibodies market (including reagents) is projected to reach USD 12.60 Billion by 2022 from USD 9.33 Billion in 2017, growing at a CAGR of 6.2% during the forecast period.
Factors such as the increasing R&D activities and expenditure in the life science industry, increasing funding for proteomics research and drug discovery, and growing collaboration between industries and academic institutes are the key drivers of the market.
The report analyzes the global research antibodies market (including reagents) by product, technology, application, end user, and region. Based on product, the market is segmented into reagents and antibodies. The reagents segment accounted for the major share of the research antibodies market (including reagents) in 2016. This can be attributed to the fact that a large number of reagents are used in various routine assays and techniques.
Furthermore, based on type, the reagents market has been further segmented into media & sera, stains & dyes, fixatives, buffers, probes, solvents, enzymes, and others (controls, stabilizers, and diluents). The media & sera segment is expected to dominate the market in 2016 due to its high usage in all types of assays, culture procedures, and techniques.
Key Market Drivers
Increasing Research Activity, Funding for R&D
Growing Industry-Academia Collaborations
Key Market Opportunities
High Growth Opportunities in Emerging Markets
Increasing Demand for Personalized Medicine and Protein Therapeutics
Growth in Stem Cell and Neurobiology Research
Increasing Focus on Biomarker Discovery
Quality Concerns Over Research Antibodies
Cost- and Time-Intensive Antibody Development Processes
Pricing Pressure Faced By Prominent Market Players